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Abstract
Objectives Knowledge on the epidemiology and long-term
course of rotator cuff calcific tendinitis (RCCT) is scarce.
We assessed demographics, radiological characteristics, and
their association with long-term outcomes in a large patient
group.
Methods Baseline demographics, radiological characteristics
and treatment were recorded in 342 patients. Interobserver
agreement of radiological measures was analyzed. Long-
term outcome was evaluated with questionnaires (WORC,
DASH). The association of baseline characteristics with out-
come was assessed.
Results Mean age was 49.0 (SD=10.0), and 59.5 % were
female. The dominant arm was affected in 66.0 %, and
21.3 % had bilateral disease. Calcifications were on average
18.7 mm (SD= 10.1, ICC= 0.84 (p < 0.001)) and located
10.1 mm (SD=11.8) medially to the acromion (ICC=0.77
(p < 0.001)). Gärtner type I calcifications were found in
32.1 % (Kappa=0.47 (p<0.001)). After 14 years (SD=7.1)
of follow-up, median WORC was 72.5 (range, 3.0-100.0;
WORC<60 in 42 %) and median DASH 17.0 (range, 0.0-
82.0). Female gender, dominant arm involvement, bilateral
disease, longer duration of symptoms, and multiple calcifica-
tions were associated with inferior WORC. DASH results
were similar.
Conclusions Many subjects have persisting shoulder com-
plaints years after diagnosis, regardless of treatment.
Female gender, dominant arm involvement, bilateral dis-
ease, longer duration of symptoms, and multiple calcifica-
tions were associated with inferior outcome. Radiological
measures had moderate-to-good reliability and no prognos-
tic value.
Key Points
• Most RCCT studies report on short-term outcome and/or
small patients groups.
• In this large, long-term observational study, RCCT ap-
peared to not be self-limiting in many subjects.
• Negative prognostic factors included female gender, more
calcifications, dominant arm affected, and longer duration
of symptoms.
• Interobserver agreement of general radiological RCCT
measures is moderate to good.
• More rigorous diagnostics and treatment might be needed
in specific RCCT cases.
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Introduction
Rotator cuff calcific tendinitis (RCCT) is frequently diag-
nosed: reported incidence rates range from 6.8–54 % [1–4].
Nevertheless, information on its epidemiology, radiological
characteristics, long-term course and prognostic factors is
scarce. In current literature, generally small populations are
assessed, with short follow-up periods. This includes a recent
trial from our institution, in which results of barbotage (nee-
dling and lavage) were superior to subacromial injections after
one year of follow-up [5]. Surprisingly, results of both treat-
ments appeared comparable in the case of Gärtner type I cal-
cifications [6]. However, the measurement properties and re-
liability of most radiological RCCT characteristics, including
the Gärtner classification, and their association with long-term
outcome are unclear.
The current observational study is the first to assess long-
term shoulder function in a large group of RCCT patients
treated with barbotage (under local anesthesia) or more con-
servative methods. Additionally, patient demographics, radio-
logical characteristics (size, location, Gärtner classification),
interobserver agreement of radiological characteristics, and
the association of these baseline parameters with long-term
outcome are evaluated.
Typical RCCT symptoms are pain in the deltoid region,
with variable functional impairment [7–9] and variable dura-
tion of symptoms, ranging from months to years [10–12].
Treatment of these generally self-limiting symptoms is usually
conservative, e.g. with non-steroidal anti-inflammatory drugs
(NSAIDs) and physical therapy. In the case of persisting or
severe symptoms, more invasive treatments can be applied,
including corticosteroids injections, barbotage, extracorporeal
shock wave therapy (ESWT), or surgery [4, 7–9, 13–38].
Only a few studies have compared various treatments and
their long-term effects. It is also unclear which patients follow
a mild and self-limiting course, or who might benefit from
more invasive treatment strategies. Consequently, clinical de-
cision making is often based on personal experience and re-
gional preferences.
With regard to the epidemiology of RCCT, several etiolo-
gies have been reported, including cell-mediated calcification,
RC degeneration, RC overuse and micro-trauma, genetic pre-
disposition, local metabolic or hemodynamic abnormalities,
and subacromial impingement [4, 39–45]. Based on these the-
ories, RCCTwould predominantly affect the dominant arm or
both arms in individuals with suboptimal vascular status (e.g.
middle to older age, diabetes, or smokers) with frequent over-
head activities. However, this has not been confirmed in clin-
ical studies.
Radiological characteristics of RCCT, including the
number, size, appearance (Gärtner classification) and loca-
tion of calcifications, have been associated with clinical
outcome by some [3, 23], but this association has been
disputed by others [16, 23, 46–49]. There is also little
knowledge of radiological calcification characteristics in
large patient groups and their measurement properties, in-
cluding reliability.
We assessed demographic and radiological characteristics
in a large group of patients with RCCT. Long-term clinical
outcomes were evaluated with questionnaires. Our objectives
were to evaluate (1) baseline demographics and radiological
characteristics, (2) interobserver agreement of common radio-
logical RCCT measures, and (3) the association of demo-
graphic and radiological characteristics with long-term shoul-
der function. More knowledge on these factors may help in
predicting patients’ prognoses and in clinical decisionmaking,
i.e. when considering more invasive treatments methods for
patients with persisting symptoms and negative prognostic
factors.
Materials and methods
Study population and baseline RCCT characteristics
Since 1980, patients referred to the Leiden UniversityMedical
Center Orthopedics department received a medical diagnosis
code. With these codes, all patients diagnosed with RCCT in
the period of January 1980 until November 2009 were identi-
fied. During most of this period, our institution was consid-
ered a center of expertise with regard to RCCTand one of few
regional institutions performing barbotage.
Medical records and radiology reports were reviewed for
eligibility criteria by the first author, who was not involved in
patient care. Patients were included if RCCTwas demonstrat-
ed on available radiographs and/or noted in the radiology re-
ports, and when aged ≥18 years at time of diagnosis. Patients
were excluded in the case that nomedical records, radiographs
or radiology reports were available, or if the diagnosis of
RCCTwas not mentioned in these records.
Accordingly, 420 had the RCCT diagnosis code. A total of
78 were excluded because no definite confirmation of RCCT
could be made after reassessing all available medical and ra-
diology records (radiographs and reports), or because they
were <18 years old, leaving 342 confirmed RCCT patients
available for the analysis of baseline demographics, radio-
graphs, and disease characteristics (Fig. 1). Furthermore, these
342 patients were the source population for the follow-up
evaluation.
The following baseline data were recorded: affected
side(s), age, gender, date of diagnosis, age at diagnosis, type
of treatment (barbotage, or conservative treatment (standard
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conservative treatment at the time included physical therapy,
NSAIDs and/or subacromial corticosteroids injections)), du-
ration of symptoms at presentation, diabetes, tendon problems
at other sites, systemic inflammatory diseases, and other sys-
temic or musculoskeletal diseases.
Follow-up and questionnaires
Addresses of the 342 patients and data on patient deaths were
checked using the municipal personal records database. All
available subjects were contacted by mail for completion of
a general information form, the Western Ontario Rotator Cuff
index (WORC), which was specifically developed to assess
shoulder function and quality of life of patients with rotator
cuff disorders, and the Disabilities of the Arm, Shoulder and
Hand score (DASH) [50–52]. Also, arm dominance, any dis-
eases for which medication was currently used, medical care
history and any diseases affecting the shoulder and arm func-
tion were recorded. Subjects indicating the latter were exclud-
ed from further analyses. Reminders were sent after 4 and
8 weeks to all subjects from whom no reply was received.
Of the 342 confirmed RCCT patients, 31 could not be
contacted due to unknown address or death. Of the remaining
311, 252 replied (81.0 %), and 194 could be included for
follow-up evaluation (Fig. 1). Demographic baseline data of
the available (194 responders) and non-available subjects are
depicted in Table 1.
As all subjects were contacted from November 2011 on-
wards, minimum follow-up was 2 years. All responders gave
Fig. 1 Study flowchart
Table 1 Baseline demographics and disease characteristics
All subjects Responders Non-
responders
n= 342 n= 194 n= 148
Female gender 203 59.5 % 115 59.3 % 88 59.5 %
Age 49.0 [21–83] 48.4 [29–83] 49.8 [21–82]
Duration of symptoms
(median, months)
23.5 [0–196] 18.0 [0–192] 24.0 [0–196]
Diabetic 17 5.0 % 10 5.2 % 7 4.7 %
Affected side
Right 161 47.1 % 88 45.4 % 73 49.3 %
Left 99 28.9 % 49 25.3 % 50 33.8 %
Both 73 21.3 % 49 25.3 % 24 16.2 %
Missing 9 2.6 % 8 4.1 % 1 0.7 %
Arm dominance
Right NA NA 165 85.9 % NA NA
Left NA NA 21 10.9 % NA NA
Other NA NA 6 3.1 % NA NA
Dominant side affected NA NA 128 66.0 % NA NA
Treatment
Barbotage 200 58.5 % 121 63.4 % 79 53.7 %
Conservative 142 41.5 % 73 36.6 % 69 46.3 %
Data displayed for all included subjects, and stratified for subjects
returning follow-up questionnaires (responders) and non-responders
Barbotage: needling and lavage under local anesthesia; Conservative: e.g.
NSAIDs, physical therapy, subacromial injections
[Range]
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written informed consent and the study was approved by the
institutional Medical Ethics Committee (study ID: P09.239).
Baseline radiological characteristics, interobserver
agreement and association with long-term outcome
Radiographs acquired within 1 year of the date of diagnosis
and before eventual barbotage were used for the evaluation of
baseline calcification characteristics. These were available for
204 shoulders in 196 patients. Due to national regulations,
radiographs older than 15 years were generally destroyed.
Radiographs were evaluated independently by two trained
researchers (PBW, RvA), blinded for the clinical status of
patients. In a consensus meeting, final radiological outcome
measures (see below) were determined for each subject. In the
case of disagreement, radiographs were re-evaluated by an
experienced musculoskeletal radiologist (MR), serving as an
adjudicator.
Affected tendon(s), Size (mm), and number of calcifica-
tions per shoulder were recorded on anteroposterior (AP) (in-
ternal and external rotation) and axial views, which are all
included in the standard shoulder protocol at our institution.
Locations of all calcific deposits in each shoulder were further
categorized using the system of Ogon et al., which we refer to
as Location [3]. With this method, a line is drawn from the
lateral border of the acromion, parallel to the glenoid, on ex-
ternal rotation AP radiographs. Location is the distance (mm)
between this line and the medial border of the calcification
(Fig. 2). More subacromial extension (negative Location val-
ue) has been reported a negative prognostic factor [3].
Calcific deposits were also assessed using Gärtners
classification: Type I calcifications have a sharp border and
a dense structure; Type II calcifications either have a sharp
border and inhomogeneous structure or a vague border and a
homogenous structure; Type III calcifications have a vague
border, and are more or less transparent, with a cloudy appear-
ance (Fig. 3) [6]. These types allegedly display the natural
course of RCCT and are potentially valuable in determining
patients’ prognosis [23]. And in a recent trial at our institution,
the results of barbotage were superior to subacromial injec-
tions in patients with Type II and III calcifications, but not in
case of Type I calcifications [5].
For assessing interobserver agreement, metric measures
(Size and Location) andGärtner classifications of all available
radiographs (analogue and digital) and all calcifications were
used (n=248 calcifications in 196 patients). To evaluate the
association of baseline radiological characteristics with long-
term outcome, characteristics of the largest calcification per
patient were used. For these final analyses, all radiographs
could be used with regard to e.g. Gärtner classification and
affected tendon, but for metric measures, only available digital
radiographs (n=50) could be used, as their magnification fac-
tor was known and consistent.
Statistical analysis
Demographics and disease characteristics were expressed
using proportions, means and standard deviations, or medians
and ranges where appropriate. Data distributions were evalu-
ated using histograms. Questionnaire data were processed
similarly. In the case of a missing WORC item, its value was
estimated by the mean of the other items in its domain, ac-
cording to instructions of the designers of the WORC. In case
of more missing values in a single domain, the questionnaire
was excluded (n=14). Similarly, 26 incomplete DASH ques-
tionnaires were excluded.
For calcification characteristics, interobserver agreement was
assessed with the Kappa statistic for Gärtner classifications,
and with paired t-tests and intraclass correlation coefficients
(ICC) for Size and Location.
In this observational study, the association of baseline char-
acteristics with long-term shoulder function was assessed with
the WORC as a primary outcome. Using logistic regression
(because of skewed outcomes for DASH and WORC scores),
the univariate association of each recorded variable with infe-
rior outcome was evaluated and expressed in odds ratios (OR)
with 95% confidence intervals (95 %-CI). WORC-scores ≥80
were defined as a good outcome. Similarly, DASH-scores ≤20
were regarded as a good outcome. Sensitivity analyses were
performed for alternative WORC and DASH cut-offs.
To gain more insight in independent prognostic factors, mul-
tivariable logistic regression models were constructed for the
WORC and DASH. In order to avoid overfitting, no more than
Fig. 2 Locations of the calcific deposits were evaluated using the system
of Ogon et al., which we refer to as Location in this paper [3]. A line
perpendicular to the most lateral border of the acromion is drawn, parallel
to the glenoid, on external rotation AP radiographs. Location is the
distance (mm) between this line and the medial border of the calcification,
where negative values represent a medial calcification border, i.e. be-
tween the glenoid and the drawn line
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10 % of the number of events were included as covariates in
each model. Variables were selected based on clinical relevance
and the univariate results (p-values ≤0.05). Because of missing
data on the duration of symptoms in several patients and the
limited number of available digital baseline radiographs, asso-
ciated variables were not entered in the multivariable models.
Statistical analyses were performed using SPSS statistics
20.0 (IBM, Armonk, New York, USA).
Results
Baseline demographics and disease characteristics
Of 342 RCCT patients, 203 (59.5 %) were female. Mean age
at diagnosis was 49.0 years (SD = 10.0). In 73 patients
(21.3 %), both arms were affected (bilateral disease).
Overall, 200 (58.5 %) underwent barbotage (Table 1).
With regard to concomitant pathologies, 17 patients were
diagnosedwith diabetes, sevenwith kidney disorders, four with
thyroid disorders, two had acromegaly and one was HIV-pos-
itive. Concomitant tendon disorders were reported in the re-
cords of 15 patients (4.4 %): 11 had had an episode of lateral
epicondylitis of the elbow, two had Achilles tendon calcifica-
tions, one had biceps tendinitis and one had fasciitis plantaris.
In the 196 patients with available baseline radiographs (248
calcifications, i.e. bilateral and multiple calcifications), the
supraspinatus tendon was affected in 167 (85.2 %), and 63
(32.1 %) had aGärtner type I calcification. Mean calcification
Sizewas 18.7 mm (SD=10.1), with a mean Locationmeasure
of -10.1 mm (SD=11.8) (Table 2). Of this subpopulation,
58.3 % underwent barbotage.
Interobserver agreement of radiological RCCT measures
For interobserver agreement, the mean difference between
observers for Size was 0.11 mm (95 %-CI: -0.46–0.67;
p=0.71) and for Location, 0.08 mm (95 %-CI: -1.16–1.00;
p=0.89), with ICCs of 0.84 (p<0.001) and 0.77 (p<0.001),
respectively. The Kappa-value for the Gärtner classification
was moderate, with a value of 0.466 (p<0.001). The Kappa-
value was 0.471 (p < 0.001) when assessing interobserver
agreement for Gärtner classification I vs. II and III combined.
Long-term shoulder function
The 194 subjects who returned questionnaires had a mean
follow-up of 14 years (SD=7.1, range 2-33, median 13 years).
Mean current age was 62 years (SD= 9.2, range 39-89).
Median WORC was 72.5 (range, 3.0-100.0) and median
DASH 17.0 (range, 0.0-82.0).
For the WORC, 99 (55 %) of 180 available subjects had a
WORC <80, and 76 (42.2 %) a WORC even below 60
(Fig. 4A). Univariate analyses demonstrated that patients with
a longer duration of symptoms at presentation, bilateral dis-
ease, and dominant arm involvement had statistically signifi-
cant lower long-term outcomes (WORC<80) (Table 3).
Additionally, with OR=1.82 (95 %-CI: 0.99-3.35, p=0.05),
female gender had a clinically relevant negative association
with long-term outcome.
In total, 106 subjects had both baseline radiographs and
clinical scores available. Results of univariate logistic
regression analyses with radiological parameters are
depicted in Tables 3 and 4. The number of calcifications
(per shoulder) had an OR= 2.1 (95 %-CI: 0.97-4.62) for
WORC<80, indicating that a larger number of calcifica-
tions was associated with inferior long-term shoulder
function in our data.
The final multivariate WORC model included gender, age
at follow-up, years after diagnosis, bilateral disease, dominant
side involvement, and treatment method. Female gender had a
significant negative effect: OR= 2.2 (95 %-CI: 1.1–4.2).
Effect sizes for bilateral disease (OR=2.2 (95 %-CI: 0.94–
5.1)) and dominant arm involvement (OR=1.7 (95 %-CI:
Fig. 3 Examples of Gärtner calcification classification types [6]. A)
Gärtner type I: sharp border and a dense structure; B) Gärtner type II:
either a sharp border and an inhomogeneous structure or a vague border
and a homogenous structure; C) Gärtner type III: a vague border, more or
less transparent in structure and a cloudy appearance
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0.79–3.6)) also indicated relevant negative effects, but did not
reach statistical significance. There was no significant associ-
ation for WORC outcome with applied treatment, either
barbotage or more conservative methods (Table 3).
Sensitivity analyses using WORC cut-off points <70 and
<90 gave similar results (data not shown).
For the DASH, 75 (44.6 %) subjects scored ≥20 points and
37 (22.0 %) subjects scored ≥40 points, indicating inferior
long-term shoulder function (Fig. 4B). There were no vari-
ables with significant effects found with univariate analyses
(Table 4). The final multivariable model for the DASH includ-
ed gender, age at questionnaire, years after diagnosis, bilateral
disease, dominant side involvement, and treatment method.
Also in this model, female gender had a statistically significant
(negative) effect: OR=2.0 (95 %-CI: 1.0–4.0) (Table 4).
Sensitivity analyses using DASH cut-off points >10 and >30
gave similar results (data not shown).
Discussion
In this first study involving both a long-term follow-up and a
large group of RCCT patients, the results show that many
subjects have persisting shoulder complaints more than a de-
cade after diagnosis, regardless of applied treatment modality
(barbotage vs. conservative). With a mean follow-up of
14 years, about 55 % had WORC scores below 80 points
and 42.2 % were even below 60 points, indicating severely
impaired shoulder function. Dominant arm involvement, bi-
lateral disease, longer duration of symptoms at presentation,
larger number of calcifications and female gender all appeared
to be negative prognostic factors for long-term shoulder func-
tion. We found no association of outcome with common ra-
diological parameters (calcification size, location, Gärtner
classification), and interobserver agreement was good for size
and location, but only moderate for the Gärtner classification.
Long-term follow-up
Previous studies on calcific tendinitis have mostly reported on
small populations with a relatively short follow-up. There are
some studies with >2 years follow-up [10, 13, 53–61], or large
patient groups (n>100) [15, 22, 34, 62–66], but the combina-
tion of both is scarce [3, 9, 11]. In one of the few larger RCCT
cohorts with a long-term follow-up, Serafini et al. report good
outcomes for both barbotage and conservative treatment, in
Table 2 Baseline data obtained from available analog (n = 154) and
digital radiographs (n = 50)
All subjects Responders Non-responders
n= 196 n= 106 n= 90
Affected tendon(s)
Supraspinatus 167 85.2 % 92 86.8 % 75 83.3 %
Infraspinatus 33 16.8 % 19 17.9 % 14 15.6 %
Subscapularis 34 17.3 % 21 19.8 % 12 13.3 %
Gärtner
1 63 32.1 % 34 32.1 % 29 32.2 %
2 111 56.6 % 65 61.3 % 46 51.1 %
3 69 35.2 % 38 35.8 % 31 34.4 %
Size (mm) 18.7 [10.1] 18.7 [9.8] 18.6 [10.8]
Location (mm) −10.1 [11.8] −10.7 [11.6] −9.1 [12.6]
There were 248 calcifications in 204 shoulders in 196 patients (multiple
calcifications in 33 shoulders) with radiographs available
Percentages are reportedwith respect to the concerning number of patients
and can be >100% because of multiple calcifications in some patients
[SD]
Fig. 4 Histograms of the clinical scores A) WORC score: 55 % had inferior long-term functional outcome, with scores below 80 percentage points; B)
DASH score: 45 % scored had scores over 20 points, indicating disability
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contrast to our results, with average Constant Scores >90
points at 10 years [9]. In accordance with our results, they
found no difference in clinical outcome between barbotage
and conservative treatment. However, their conservative
group consisted of patients refusing to undergo barbotage,
who instead underwent unreported other treatment methods
and had a high drop-out rate. A possible explanation for their
superior results is that the mean age at diagnosis was
40.2 years, compared to our 49.0 years. Also, RCCT was
diagnosed in 323 shoulders in ±3 years, versus 420 patients
in 29 years at our institution. The latter might be partially due
to both the high density of hospitals and the fact that a general
practitioner functions as a gatekeeper for the referral to a med-
ical specialist in our country. Both can potentially limit the
referral of patients for treatment, specifically in cases with mild
symptoms. Finally, it is possible that referring physicians are
more familiar with RCCTand its treatment in the geographical
region of Serafini. This could lead to earlier diagnosis, at a
younger age, and earlier referral and adequate treatment.
Concordantly, our univariate analyses show that longer dura-
tion of symptoms at presentation is related to inferior long-term
outcome. Lastly, the Constant Score as applied by Serafini et al.
is a general shoulder function score, in contrast to the WORC,
which is a validated score for rotator cuff problems specifically.
Demographics and prognostic characteristics
Dominant arm involvement was associated with inferior long-
term outcome. A plausible explanation is that dominant arm
involvement has a larger influence on the patient’s life. The
dominant arm was also more often affected than the non-
dominant arm. This is in contrast to most studies that either
find no influence of arm dominance on outcome, or did not
analyze this effect [9, 67, 68]. Bilateral disease had a negative
association with clinical outcome, which is supported by
others [3, 16].
The higher incidence of RCCT in women is in accordance
with most other studies. Some explain this by the higher prev-
alence of endocrine disorders in women (thyroid and estrogen
metabolism) [67]. Of all recorded thyroid disorders we iden-
tified from the medical records, the majority (75 %) was in
females. Similarly, of all patients with concomitant tendon
disorders, 66.6 % were female. Although these data are prob-
ably underreported and we did not investigate underlying
Table 3 Univariate and
multivariate analyses of the
associations of baseline
characteristics with inferior long-
term clinical outcome, expressed
in a WORC score <80 points
WORC< 80 Univariate Multivariate
OR 95 % CI p OR 95 % CI p
Female gender 1.82 0.99–3.35 0.05 2.16 1.11− 420 0.02
Age diagnosis 1.00 0.97− 1.04 0.83
Age questionnaire 1.02 0.98− 1.05 0.36 1.00 0.96− 1.04 0.85
Years after diagnosis 1.02 0.98− 1.06 0.35 0.99 0.94− 1.04 0.68
Diabetic 3.01 0.61− 14.89 0.18
Duration of symptoms (per additional month) 1.02 1.00− 1.03 0.01
Bilateral disease 2.63 1.24− 5.57 0.01 2.18 0.94− 5.10 0.07
Dominant side affected 2.00 1.01− 3.96 0.05 1.69 0.79− 3.60 0.18
Affected tendon(s)
Supraspinatus 0.73 0.23− 2.31 0.59
Infraspinatus 1.07 0.43− 2.64 0.89
Subscapularis 1.17 0.32− 4.26 0.82
Treatment
Barbotage 1.00 0.54− 1.86 0.99 1.13 0.56− 2.28 0.74
Calcification location (mm) 0.98 0.92− 1.06 0.63
Calcification size (mm) 0.98 0.91− 1.06 0.64
Gärtner calcification classification 0.87
1 Ref.
2 0.93 0.36− 2.39 0.89
3 1.19 0.42− 3.36 0.75
Number of calcifications (per additional deposit) 2.12 0.97− 4.62 0.06
Radiological data were available in 204 patients for Gärtner classification, affected tendon, and number of
calcifications (analogue and digital radiographs), and in 50 patients for Size and Location (digital radiographs,
calibrated). These data were not included in the multivariate analysis
95 %-CI: 95 %-Confidence Interval
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associations, our results confirm a higher incidence of RCCT
in the presence of systemic diseases in women.
We found no effect of treatment (barbotage vs. conserva-
tive) on long-term outcome. Because of the alleged self-
limiting character of RCCT, treatment is usually conservative
[4, 16, 57]. However, as supported by our results, symptoms
can persist for more than a decade. Various more invasive
methods have been reported for patients with severe or
persisting symptoms, including ESWT [26, 28, 29], barbotage
[9, 15, 19, 34, 38], and surgery [13, 14]. But reported out-
comes are highly variable and only a few studies compare
treatment methods. More research is needed to gain knowl-
edge on indications and long-term effects of various treatment
methods, specifically for the more invasive techniques.
Radiological measures and prognostic characteristics
This is one of the first studies assessing interobserver agree-
ment and the prognostic value of radiological characteristics
of calcifications: the Gärtner classification [6], calcification
Size, and the Location measure of Ogon et al [3]. Both metric
measures (Size, Location) had good ICCs and small mean
interobserver differences. For the Gärtner classification, there
was only moderate agreement (Kappa 0.47), comparable to
previously reported values in a smaller patient group [48].
Our previous study showed, that the results of barbotage were
particularly superior to subacromial injections in patients with
Type II and III calcifications [6]. Therefore, we also assessed
interobserver agreement for Type I vs. Type II/III calcifica-
tions, but there was a similar moderate agreement. Overall,
we found no prognostic value of radiological characteristics.
Confirmatory to this, others have reported that symptoms and
treatment outcome do not depend on the calcific deposit clas-
sification and size at baseline, but patients with radiological
improvement over time (e.g. decrease in size or Gärtner clas-
sification) do report better clinical results [16, 46]. The latter
was not investigated in our study. However, we did find a
relevant association between a higher number of calcifications
at baseline and inferior long-term outcome.
Strengths and limitations
There are some limitations that have to be taken into account
when interpreting our results. Firstly, as with all retrospective
Table 4 Univariate and
multivariate analyses of the
associations of baseline
characteristics with inferior long-
term clinical outcome, expressed
in a DASH >20 points
Dash> 20 Univariate Multivariate
OR 95 % CI p OR 95 % CI p
Female gender 1.58 0.85− 2.97 0.15 2.03 1.02− 4.02 0.04
Age diagnosis 1.01 0.98− 1.05 0.49
Age questionnaire 1.01 0.98− 1.05 0.57 1.01 0.97− 1.05 0.64
Years after diagnosis 1.00 0.96− 1.04 0.98 1.01 0.95− 1.07 0.79
Diabetic 2.61 0.63− 10.8 0.19
Duration of symptoms (per additional month) 1.01 0.99− 1.02 0.13
Bilateral disease 1.61 0.79− 3.25 0.19 1.49 0.62− 3.13 0.42
Dominant side affected 2.07 0.99− 4.33 0.05 1.92 0.85− 4.32 0.12
Affected tendon(s)
Supraspinatus 0.44 0.15− 1.30 0.14
Infraspinatus 1.11 0.46− 2.72 0.81
Subscapularis 1.88 0.57− 6.21 0.30
Treatment
Barbotage 0.76 0.41− 1.44 0.40 0.64 0.31− 1.31 0.22
Calcification location (mm) 1.02 0.95− 1.09 0.61
Calcification size (mm) 0.98 0.91− 1.06 0.64
Gärtner calcification classification 0.53
1 Ref.
2 1.08 0.40− 2.95 0.88
3 1.71 0.59− 5.02 0.33
Number of calcifications (per additional deposit) 1.19 0.62− 2.28 0.61
Radiological data were available in 204 patients for Gärtner classification, affected tendon, and number of
calcifications (analogue and digital radiographs); and in 50 patients for Size and Location (digital radiographs,
calibrated). These data were not included in the multivariate analysis
95 %-CI: 95 %-Confidence Interval
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studies, a substantial part of our data depends on accurate med-
ical record keeping. Furthermore, selection bias could have
played a role; 194 of 342 subjects could be included for the
follow-up part of our study, and only a limited number also had
radiographs available. However, the baseline characteristics of
subjects who did not sent a reply were comparable to the eval-
uated subjects (Tables 1 and 2). Furthermore, sensitivity analy-
ses including only subjects who had both radiographs and clin-
ical scores available showed similar results (Supplementary
Table S1). And despite the above, this is one of the largest
studies with the longest follow-up of its kind.
Secondly, it is unclear whether the inferior long-term shoul-
der scores are due to persisting, residual, or recurrent RCCT,
or other shoulder pathology (whether or not consequent to
RCCT). Although it would be interesting to know whether
subjects with inferior outcomes actually still have RCCT, the
fact that many subjects (formerly) diagnosed with RCCT have
serious symptoms in the long-term is very relevant informa-
tion by itself: the clinical scores of many subjects in this study
are inferior compared to the general population, even years
after diagnosis. This is one of the first studies showing this
phenomenon. Further research is needed to investigate under-
lying conditions in the long-term course of RCCT.
Thirdly, it is possible that some patients might have had
(secondary) treatments in other institutions. However, our insti-
tutionwas one of few regional centers performing barbotage and
other RCCT treatments during the study period. Furthermore,
despite potential secondary treatments, we still found persisting
symptoms in many subjects after more than a decade.
Lastly, there could have been confounding by indication.
Patients who had barbotage are likely to have had other or
more serious symptoms. Taking long-term outcome into ac-
count, OR’s of treatment method were around 1.0 for WORC
and DASH, meaning that if specifically patients with worse
symptoms in the past had a barbotage, they had no inferior
long-term outcome compared to the more conservatively
treated patients.
Conclusions
In this observational study, we found that over 55 % of RCCT
patients, treated with either barbotage or more conservative
modalities, have symptoms and impaired shoulder function
at a mean of 14 years after diagnosis. These observations are
in contrast to the general view that RCCT is a self-limiting
disease. Dominant arm involvement, bilateral disease, a larger
number of calcifications, female gender, and longer duration
of symptoms were associated with inferior functional out-
come. We found no associations between treatment method
and baseline radiological characteristics with long-term out-
come. Interobserver agreement of the radiological Gärtner
classification was only moderate.
Applying these findings in clinical decision making
might be helpful in preventing a long-term symptomatic
course; it is plausible that a wait-and-see strategy or con-
servative treatments (not aimed at decreasing the calcium
deposits) are not necessarily the most effective methods in
patients with persisting symptoms, no signs of resorption over
time, and one or more of the reported negative prognostic
factors. We suggest taking into account these factors in future
(prospective) studies, in order to evaluate whether earlier-
applied and more invasive forms of treatment result in better
outcome in selected patients.
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